Charitable entity of ReposiTrak (TRAK) CEO sells 7,500 shares
Rhea-AI Filing Summary
ReposiTrak, Inc. director and CEO Randall K. Fields reported pre-planned insider sales executed by a charitable entity associated with him. RK Fields Charitable 2022, LLC sold a total of 7,500 shares of ReposiTrak common stock in open-market transactions on
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the related charitable trust to help meet charitable commitments. After these sales, that LLC held 77,500 shares. The Form 4 also shows Fields continues to hold 3,483,955 ReposiTrak common shares directly, plus additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
Positive
- None.
Negative
- None.
Insights
Pre-planned charitable sales of 7,500 ReposiTrak shares look routine relative to Fields’ large remaining stake.
The Form 4 shows a charitable LLC associated with CEO Randall K. Fields sold 7,500 ReposiTrak common shares over two days at prices slightly above
This pattern is typically viewed as a weak information signal because timing is pre-set rather than discretionary. Context matters: Fields still directly owns 3,483,955 common shares, and the charitable LLC retains 77,500 shares, alongside other indirect positions. Together, these figures indicate he continues to have substantial exposure to ReposiTrak equity despite the modest net sell activity.
FAQ
What insider transactions did ReposiTrak (TRAK) report for Randall K. Fields?
Who actually sold the ReposiTrak (TRAK) shares disclosed in this Form 4?
Why were the ReposiTrak (TRAK) shares sold under a Rule 10b5-1 plan?
What price range did the ReposiTrak (TRAK) insider sales occur at?
How many ReposiTrak (TRAK) shares does Randall K. Fields still hold after these trades?
Does the ReposiTrak (TRAK) Form 4 indicate any derivative exercises or option activity?